Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
GenesWell BCT
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Gencurix
Type:
Other Approval
Related tests:
‹
COLO eDX
Droplex BRAF Mutation Test
Droplex EGFR Mutation Test v2
Droplex KRAS Mutation Test
Droplex PIK3CA Mutation Test
Droplex POLE Mutation Test
Droplex c-Met Exon14 Skipping Test
GenesWell ddEGFR Mutation Test
HEPA eDX
COLO eDX
Droplex BRAF Mutation Test
Droplex EGFR Mutation Test v2
Droplex KRAS Mutation Test
Droplex PIK3CA Mutation Test
Droplex POLE Mutation Test
Droplex c-Met Exon14 Skipping Test
GenesWell ddEGFR Mutation Test
HEPA eDX
›
Details
Evidence
News
GenesWell Breast Cancer Test (BCT) is a multigene assay that predicts the risk of distant recurrence in patients with early breast cancer.
Cancer:
Breast Cancer
Gene:
ER (Estrogen receptor), HER-2 (Human epidermal growth factor receptor 2), PGR (Progesterone receptor)
ER (Estrogen receptor), HER-2 (Human epidermal growth factor receptor 2), PGR (Progesterone receptor)
Method:
RT-PCR
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login